- £75.51m
- £157.16m
- £141.88m
- 30
- 98
- 50
- 64
Annual income statement for Anexo, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 86.8 | 118 | 138 | 149 | 142 |
Cost of Revenue | |||||
Gross Profit | 68 | 91.5 | 106 | 118 | 103 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 68.7 | 90.9 | 108 | 110 | 116 |
Operating Profit | 18.1 | 27.4 | 30.4 | 39.8 | 25.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 15.5 | 23.7 | 24.1 | 23 | 14.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.3 | 19.1 | 19.5 | 15.1 | 11.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 12.3 | 19.1 | 19.5 | 15.1 | 11.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 12.3 | 19.1 | 19.5 | 15.1 | 11.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.105 | 0.161 | 0.164 | 0.132 | 0.099 |
Dividends per Share |